Coronavirus News and Research

RSS
SARS-CoV-2 variants of concern employ different strategies of antibody escape

SARS-CoV-2 variants of concern employ different strategies of antibody escape

How do people with post acute sequelae of COVID-19 react to SARS-CoV-2 vaccines?

How do people with post acute sequelae of COVID-19 react to SARS-CoV-2 vaccines?

Immunity to SARS-CoV-2 in renal transplant and dialysis patients using Pfizer/BioNTech and Moderna vaccines

Immunity to SARS-CoV-2 in renal transplant and dialysis patients using Pfizer/BioNTech and Moderna vaccines

SARS-CoV-2 spike-specific antibodies induced in breast milk by COVID-19 vaccines

SARS-CoV-2 spike-specific antibodies induced in breast milk by COVID-19 vaccines

Study suggests mRNA SARS-CoV-2 vaccines remain effective against variants

Study suggests mRNA SARS-CoV-2 vaccines remain effective against variants

Impaired immune response to SARS-CoV-2 mRNA vaccination in immunocompromised patients

Impaired immune response to SARS-CoV-2 mRNA vaccination in immunocompromised patients

Return to play can be managed for athletes with genetic heart diseases, study suggests

Return to play can be managed for athletes with genetic heart diseases, study suggests

Facebook poll suggests breakthrough infections are linked to long COVID

Facebook poll suggests breakthrough infections are linked to long COVID

Scientists uncover genetics involved in COVID-19 induced respiratory failure

Scientists uncover genetics involved in COVID-19 induced respiratory failure

Study shows inhalable nanocatchers can protect lung cells against SARS-CoV-2

Study shows inhalable nanocatchers can protect lung cells against SARS-CoV-2

Want fries with that vaccine? Even at a fast-food restaurant, pop-up clinics see slow traffic

Want fries with that vaccine? Even at a fast-food restaurant, pop-up clinics see slow traffic

Monoclonal antibody CT-P59 demonstrates potent antiviral efficacy against SARS-CoV-2 delta variant

Monoclonal antibody CT-P59 demonstrates potent antiviral efficacy against SARS-CoV-2 delta variant

Scientists identify an antiviral metabolite as a potential serum biomarker for SARS-CoV-2 infection

Scientists identify an antiviral metabolite as a potential serum biomarker for SARS-CoV-2 infection

SARS-CoV-2 interacts with unusual RNA structures in human cells

SARS-CoV-2 interacts with unusual RNA structures in human cells

One dose of mRNA vaccine reduced COVID risk for at least four months in health care workers

One dose of mRNA vaccine reduced COVID risk for at least four months in health care workers

Budesonide’s antiviral effect against SARS-CoV-2

Budesonide’s antiviral effect against SARS-CoV-2

A novel interferon-γ release assay for detection of SARS-CoV-2 specific T-cell response

A novel interferon-γ release assay for detection of SARS-CoV-2 specific T-cell response

CDC study on efficacy of mRNA vaccines against symptomatic COVID-19

CDC study on efficacy of mRNA vaccines against symptomatic COVID-19

New statistical framework could help determine the 'true prevalence' of COVID-19 pandemic

New statistical framework could help determine the 'true prevalence' of COVID-19 pandemic

Sick leave eligibility rules in the U.S. widen racial inequalities in the labor market, finds study

Sick leave eligibility rules in the U.S. widen racial inequalities in the labor market, finds study